Literature DB >> 25764956

Comparative study of two antimicrobial dressings in infected leg ulcers: a pilot study.

G Mosti1, A Magliaro, V Mattaliano, P Picerni, N Angelotti.   

Abstract

OBJECTIVE: The aim of the study was to compare the efficacy of a microorganism-binding (MB) dressing with a silver-containing hydrofiber (SCH) dressing in controlling the bacterial loads of heavily colonised or locally infected chronic venous leg ulcers, before surgical management with homologous skin grafts.
METHOD: A randomised comparative single centre study recruited patients presenting with hard-to-heal critically colonised or locally infected leg ulcers, who could be treated with skin grafting. Inclusion criteria included; ulcers of vascular aetiology, over 18 years old, a wound duration ≥6 months and ankle brachial index (ABPI) >0.6. Patients were randomly assigned to treatment with SCH dressings (Aquacel Ag) or MB dressing (Cutimed Sorbact). Dressings were changed daily over a four-day observation period, after which they were taken for a skin grafting procedure. Swab samples from ulcer beds were taken in order to quantify the bacterial load at inclusion (D0) and at the end of the observation period day 4 (D4). No antibiotics were administered before or during the evaluation period.
RESULTS: Both groups (n=20 SCH, n=20 MB) were similar in gender, age, pathophysiology (both had 15 patients with venous leg ulcers and 5 with arterial leg ulcers), ulcer surface, ulcer duration, treatment-related pain and initial bacterial load. Analysing bacterial load variation showed a significant reduction of bacterial burden at D4 in both groups. In the SCH group, we found an average bacterial load reduction of 41.6%, with an average reduction of 73.1% in the MB group (p< 0.00001). No serious adverse events were reported.
CONCLUSION: Our evaluation confirmed that MB and SCH dressings are effective in reducing the bacterial burden in critically colonised or locally infected chronic leg ulcers, without inducing adverse events, with MB dressings significantly more effective. DECLARATION OF INTEREST: There were no external sources of funding for this study. The authors have no conflicts of interest to declare.

Entities:  

Keywords:  antimicrobial dressing; bacterial load; efficacy; infection; leg ulcers; skin allograft

Mesh:

Substances:

Year:  2015        PMID: 25764956     DOI: 10.12968/jowc.2015.24.3.121

Source DB:  PubMed          Journal:  J Wound Care        ISSN: 0969-0700            Impact factor:   2.072


  10 in total

1.  Design and Development of Neomycin Sulfate Gel Loaded with Solid Lipid Nanoparticles for Buccal Mucosal Wound Healing.

Authors:  Khaled M Hosny; N Raghavendra Naveen; Mallesh Kurakula; Amal M Sindi; Fahad Y Sabei; Adel Al Fatease; Abdulmajeed M Jali; Waleed S Alharbi; Rayan Y Mushtaq; Majed Felemban; Hossam H Tayeb; Eman Alfayez; Waleed Y Rizg
Journal:  Gels       Date:  2022-06-16

2.  Impact of Gram-negative bacteria on the treatment of venous leg ulcers.

Authors:  Wibke L Engelberg; Martin Dörler; Markus Stücker; Stefanie Reich-Schupke
Journal:  Int Wound J       Date:  2018-08-05       Impact factor: 3.315

Review 3.  Wound Care for Venous Ulceration.

Authors:  Sarah E Schroeppel DeBacker; Julie C Bulman; Jeffrey L Weinstein
Journal:  Semin Intervent Radiol       Date:  2021-06-03       Impact factor: 1.780

4.  Randomized Controlled Trial Evaluating Dialkylcarbamoyl Chloride Impregnated Dressings for the Prevention of Surgical Site Infections in Adult Women Undergoing Cesarean Section.

Authors:  Paweł Jan Stanirowski; Magdalena Bizoń; Krzysztof Cendrowski; Włodzimierz Sawicki
Journal:  Surg Infect (Larchmt)       Date:  2016-02-18       Impact factor: 2.150

5.  Budget impact of antimicrobial wound dressings in the treatment of venous leg ulcers in the German outpatient care sector: a budget impact analysis.

Authors:  Maria Gueltzow; Poroshat Khalilpour; Katharina Kolbe; York Zoellner
Journal:  J Mark Access Health Policy       Date:  2018-11-01

6.  Development of polyurethane foam dressing containing silver and asiaticoside for healing of dermal wound.

Authors:  Nantaporn Namviriyachote; Vimolmas Lipipun; Yada Akkhawattanangkul; Phingphol Charoonrut; Garnpimol C Ritthidej
Journal:  Asian J Pharm Sci       Date:  2018-10-15       Impact factor: 6.598

Review 7.  Strategies and challenges in the treatment of chronic venous leg ulcers.

Authors:  Shi-Yan Ren; Yong-Sheng Liu; Guo-Jian Zhu; Meng Liu; Shao-Hui Shi; Xiao-Dong Ren; Ya-Guang Hao; Rong-Ding Gao
Journal:  World J Clin Cases       Date:  2020-11-06       Impact factor: 1.337

8.  Effect of a DACC-coated dressing on keratinocytes and fibroblasts in wound healing using an in vitro scratch model.

Authors:  Bianka Morgner; Johanna Husmark; Anna Arvidsson; Cornelia Wiegand
Journal:  J Mater Sci Mater Med       Date:  2022-02-08       Impact factor: 3.896

Review 9.  Dressings and topical agents for treating venous leg ulcers.

Authors:  Gill Norman; Maggie J Westby; Amber D Rithalia; Nikki Stubbs; Marta O Soares; Jo C Dumville
Journal:  Cochrane Database Syst Rev       Date:  2018-06-15

10.  Assessing the effectiveness of dialkylcarbamoylchloride (DACC)-coated post-operative dressings versus standard care in the prevention of surgical site infection in clean or clean-contaminated, vascular surgery (the DRESSINg trial): study protocol for a pilot feasibility randomised controlled trial.

Authors:  Joshua P Totty; Amy E Harwood; Paris L Cai; Louise H Hitchman; George E Smith; Ian C Chetter
Journal:  Pilot Feasibility Stud       Date:  2019-01-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.